687
Views
2
CrossRef citations to date
0
Altmetric
Original Articles: Diagnostic and Prognostic Markers

Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor

ORCID Icon, , , , , , , , , , , , & show all
Pages 1263-1267 | Received 26 Mar 2022, Accepted 13 Oct 2022, Published online: 28 Oct 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Gabriele Roccuzzo, Cristina Sarda, Valentina Pala, Simone Ribero & Pietro Quaglino. (2024) Prognostic biomarkers in melanoma: a 2023 update from clinical trials in different therapeutic scenarios. Expert Review of Molecular Diagnostics 24:5, pages 379-392.
Read now
Gabriele Roccuzzo, Eleonora Bongiovanni, Luca Tonella, Valentina Pala, Sara Marchisio, Alessia Ricci, Rebecca Senetta, Luca Bertero, Simone Ribero, Enrico Berrino, Caterina Marchiò, Anna Sapino, Pietro Quaglino & Paola Cassoni. (2024) Emerging prognostic biomarkers in advanced cutaneous melanoma: a literature update. Expert Review of Molecular Diagnostics 24:1-2, pages 49-66.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.